Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Photoelectron Corp. (PECN : OTC)
 
 • Company Description   
Photoelectron Corporation (PeC) upon inception, initially focused on research and development for the miniaturization of an x-ray system for cancer treatment. It creates and adapts miniature x-ray systems for various applications in healthcare and non-healthcare related markets. PeC offers micro-adaptive x-ray systems designed for x-ray fluorescence analysis, intravascular radiation therapy, brachytherapy, radiosurgery, intra-operative radiation therapy, and instrumentation to the industrial and medical markets through original equipment manufacturers. LASER-X is Photoelectron's non-medical miniature x-ray source for x-ray fluorescence analysis, a recognized method of measuring the atomic composition of a material. PeC has produced X-Seed, a prototype of a new system for delivering x-rays from inside blood vessels following an operation for clogged arteries. The X-Seed technology has the potential for brachytherapy with minimal modifications from the intravascular product.

Number of Employees:

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.02 Daily Weekly Monthly
20 Day Moving Average: 5 shares
Shares Outstanding: (millions)
Market Capitalization: $ (millions)
Beta: 3.84
52 Week High: $0.02
52 Week Low: $0.02
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 0.00% 12.62%
12 Week 0.00% 9.93%
Year To Date 0.00% 22.18%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
5 FORBES ROAD
-
LEXINGTON,MA 02421
USA
ph: 617-861-2069
fax: 781-259-0482
None http://www.photoelectron.com
 
 • General Corporate Information   
Officers
Peter M. Nomikos - Chairman;President and Chief Executive Officer
Timothy W. Baker - Executive Vice President; Chief Financial Officer
Roger D. Wellington - Director
Dr. Leonard Laster - Director
Thomas J. Miller - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 719320103
SIC: 3845
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: -
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding:
Most Recent Split Date: (:1)
Beta: 3.84
Market Capitalization: $ (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -
12/31/21 - -
09/30/21 - -
Current Ratio
03/31/22 - -
12/31/21 - -
09/30/21 - -
Quick Ratio
03/31/22 - -
12/31/21 - -
09/30/21 - -
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - -
12/31/21 - -
09/30/21 - -
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Capital
03/31/22 - -
12/31/21 - -
09/30/21 - -
 

Powered by Zacks Investment Research ©